NVDA
NVIDIA
-- 145.431 PLTR
Palantir
-- 68.885 SMCI
Super Micro Computer
-- 41.660 MRVL
Marvell Technology
-- 118.464 TSLA
Tesla
-- 353.340 
NEWS
Phio Pharmaceuticals to Participate in the Renmark Financial Communications Virtual Non-Deal Roadshow Series
Tuesday, 3rd December at 7:45 am
Registration Link for Presentation and live Q&A to take place, Tuesday, December 10, 2024 at 12:00 pm EST
Marlborough, Massachusetts--(Newsfile Corp. - December 3, 2024) - Phio Pharmaceuticals Corp. (NASDAQ: PHIO) is a clinical-stage biotechnology company developing therapeutics that use its INTASYL® siRNA gene silencing technology designed to make the body's immune cells more effective in killing cancer cells. Phio announced today that management will present in the live Virtual Non-Deal Roadshow Series hosted by Renmark Financial Communications Inc.
Mr. Robert Bitterman, CEO and Chairman of the Board, Phio Pharmaceuticals will present on Tuesday, December 10 at 12:00 pm EST. A replay of the event may be accessed on the Renmark Financial Communications Inc. website
Tuesday, 3rd December at 7:45 am
Registration Link for Presentation and live Q&A to take place, Tuesday, December 10, 2024 at 12:00 pm EST
Marlborough, Massachusetts--(Newsfile Corp. - December 3, 2024) - Phio Pharmaceuticals Corp. (NASDAQ: PHIO) is a clinical-stage biotechnology company developing therapeutics that use its INTASYL® siRNA gene silencing technology designed to make the body's immune cells more effective in killing cancer cells. Phio announced today that management will present in the live Virtual Non-Deal Roadshow Series hosted by Renmark Financial Communications Inc.
Mr. Robert Bitterman, CEO and Chairman of the Board, Phio Pharmaceuticals will present on Tuesday, December 10 at 12:00 pm EST. A replay of the event may be accessed on the Renmark Financial Communications Inc. website
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment